Literature DB >> 18635697

D1 receptor antagonist-induced long-term depression in the medial prefrontal cortex of rat, in vivo: an animal model of psychiatric hypofrontality.

Rd Coppa-Hopman1, J Galle, D Pimkine.   

Abstract

The objective of the following experiment was to induce a pathogenic hypofrontal condition by administering a dopamine-1 receptor (D(1)R) antagonist to rats. The pathophysiological effect of this manipulation upon glutamate-based long-term potentiation (LTP) in the medial prefrontal cortex (mPFC) was examined in vivo. Subjects were surgically implanted with stimulating electrodes into the corpus callosum and recording electrodes into the mPFC. High-frequency stimulation (HFS) was combined with the administration of the selective D(1)R family agonist A68930 hydrochloride (0.4 mg/kg/mL) and the selective D(1)R family antagonist SKF 83566 (0.15 mg/kg/mL). The administration of SKF 83566 hydrobromide prevented mPFC LTP, and resulted in HFS-induced long-term depression. This indicates that D(1)R activation is necessary for the induction of mPFC glutamate-based LTP. This is supported by our finding that the administration of A68930 hydrochloride combined with HFS induced LTP comparable with saline control levels, suggesting that D(1)R activation is necessary for the induction of baseline levels of mPFC LTP. Given that the mPFC governs executive behaviours that are subserved by LTP, such as working memory, these findings are relevant for the study of psychopathological conditions in which hypodopaminergic conditions exist in the mPFC and are correlated with psychiatric symptomotology, such as drug addiction and schizophrenia.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18635697     DOI: 10.1177/0269881108091256

Source DB:  PubMed          Journal:  J Psychopharmacol        ISSN: 0269-8811            Impact factor:   4.153


  6 in total

1.  SKF-83566, a D1-dopamine receptor antagonist, inhibits the dopamine transporter.

Authors:  Melissa A Stouffer; Solav Ali; Maarten E A Reith; Jyoti C Patel; Federica Sarti; Kenneth D Carr; Margaret E Rice
Journal:  J Neurochem       Date:  2011-07-21       Impact factor: 5.372

Review 2.  Reviewing the ketamine model for schizophrenia.

Authors:  Joel Frohlich; John D Van Horn
Journal:  J Psychopharmacol       Date:  2013-11-20       Impact factor: 4.153

Review 3.  Dopamine Receptors: Is It Possible to Become a Therapeutic Target for Depression?

Authors:  Fangyi Zhao; Ziqian Cheng; Jingjing Piao; Ranji Cui; Bingjin Li
Journal:  Front Pharmacol       Date:  2022-08-17       Impact factor: 5.988

4.  A new strategy for antidepressant prescription.

Authors:  Francis Lavergne; Thérèse M Jay
Journal:  Front Neurosci       Date:  2010-11-19       Impact factor: 4.677

5.  Dopamine terminals from the ventral tegmental area gate intrinsic inhibition in the prefrontal cortex.

Authors:  William C Buchta; Stephen V Mahler; Benjamin Harlan; Gary S Aston-Jones; Arthur C Riegel
Journal:  Physiol Rep       Date:  2017-03

6.  Synaptic Impairment in Layer 1 of the Prefrontal Cortex Induced by Repeated Stress During Adolescence is Reversed in Adulthood.

Authors:  Ignacio Negrón-Oyarzo; Alexies Dagnino-Subiabre; Pablo Muñoz Carvajal
Journal:  Front Cell Neurosci       Date:  2015-11-12       Impact factor: 5.505

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.